DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+5.67%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$1.77B
AUM Growth
+$1.77B
(-10%)
Cap. Flow
-$252M
Cap. Flow
% of AUM
-14.22%
Top 10 Holdings %
Top 10 Hldgs %
36.41%
Holding
135
New
25
Increased
19
Reduced
28
Closed
30
Top Buys
| 1 |
QCOR
QUESTCOR PHARMA INC
QCOR
|
$69.3M |
| 2 |
Humana
HUM
|
$42.8M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$35.3M |
| 4 |
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
|
$33.7M |
| 5 |
DaVita
DVA
|
$30.7M |
Top Sells
| 1 |
Pfizer
PFE
|
$51.8M |
| 2 |
AstraZeneca
AZN
|
$48.2M |
| 3 |
AbbVie
ABBV
|
$45M |
| 4 |
Teva Pharmaceuticals
TEVA
|
$35.5M |
| 5 |
THOR
THORATEC CORPORATION
THOR
|
$33.2M |
Sector Composition
| 1 | Healthcare | 50.15% |
| 2 | Financials | 1.26% |
| 3 | Technology | 0.81% |
| 4 | Industrials | 0.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Tempest Therapeutics
TPST
$44M
| $5.54M | 0.29% | 605,561 -1,900 | -0.3% | -$17.4K |
|
|
CASM
52
DELISTED
CAS Medical Systems, Inc.
CASM
| $5.44M | 0.28% | 3,200,000 | – | – |
|
|
AERI
53
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $5.39M | 0.28% | +300,000 | New | +$5.39M |
|
|
ANTH
54
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $5.19M | 0.27% | 1,691,857 | – | – |
|
|
VYNT
55
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
| $4.88M | 0.25% | +354,180 | New | +$4.88M |
|
56
Geron
GERN
$893M
| $4.74M | 0.25% | +1,000,000 | New | +$4.74M |
|
57
Nuwellis
NUWE
$4.6M
| $4.2M | 0.22% | +432,000 | New | +$4.2M |
|
|
BIND
58
DELISTED
BIND THERAPEUTICS INC
BIND
| $3.87M | 0.2% | +256,384 | New | +$3.87M |
|
|
CEMP
59
DELISTED
Cempra, Inc.
CEMP
| $3.84M | 0.2% | 309,655 -493,861 | -61% | -$6.12M |
|
|
LCAV
60
DELISTED
LCA-VISION INC
LCAV
| $2.85M | 0.15% | 730,856 | – | – |
|
|
OCRX
61
DELISTED
Ocera Therapeutics, Inc.
OCRX
| $2.74M | 0.14% | +211,119 | New | +$2.74M |
|
62
Gyre Therapeutics
GYRE
$703M
| $2.56M | 0.13% | +617,000 | New | +$2.56M |
|
|
KIN
63
DELISTED
Kindred Biosciences, Inc.
KIN
| $2.51M | 0.13% | +225,000 | New | +$2.51M |
|
|
STRM
64
DELISTED
Streamline Health Solutions
STRM
| $2.27M | 0.12% | +325,000 | New | +$2.27M |
|
65
Rigel Pharmaceuticals
RIGL
$697M
| $2.18M | 0.11% | 763,675 -304,051 | -28% | -$866K |
|
|
NVDQ
66
DELISTED
Novadaq Technologies Inc.
NVDQ
| $1.98M | 0.1% | +120,010 | New | +$1.98M |
|
67
Arrowhead Research
ARWR
$3.05B
| $1.54M | 0.08% | +142,017 | New | +$1.54M |
|
|
PTN
68
DELISTED
Palatin Technologies
PTN
| $1.47M | 0.08% | 2,000,000 | – | – |
|
|
HMSY
69
DELISTED
HMS Holdings Corp.
HMSY
| $1.31M | 0.07% | +57,800 | New | +$1.31M |
|
|
ECYT
70
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $1.2M | 0.06% | 111,967 +61,537 | +122% | +$657K |
|
71
Amgen
AMGN
$155B
| $1.14M | 0.06% | +10,000 | New | +$1.14M |
|
|
ARTC
72
DELISTED
ARTHROCARE CORP
ARTC
| $805K | 0.04% | +20,000 | New | +$805K |
|
73
Savara
SVRA
$567M
| $678K | 0.04% | 1,466,249 -1,167,972 | -44% | -$540K |
|
74
Option Care Health
OPCH
$4.65B
| $518K | 0.03% | 70,022 -1,179,019 | -94% | -$8.72M |
|
75
HCA Healthcare
HCA
$94.5B
| $477K | 0.02% | +10,000 | New | +$477K |
|